Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05904782

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

To learn more about the experience and wellbeing of people who provide care for cancer patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Juliet Kroll, BA, PHD

PRINCIPAL_INVESTIGATOR

Juliet Kroll, BA,PHD

CONTACT

[email protected]

346-723-5858

About this study

OBJECTIVES

Primary Objectives:

The primary objective of this proposal is to identify relevant themes and content essential to adapt PAT to a caregiving in advanced cancer context (PAT-C) and develop a Brief (5-session) version of PAT-C. Findings from this study are essential to inform future RCTs to test the feasibility, efficacy, dose and explore potential mediators of treatment outcomes of this intervention.

Secondary Objectives:

The secondary objective is to characterize psychosocial distress and psychosocial health of caregivers in the supportive care clinic. This data will be essential to inform appropriateness of the supportive care clinic as a potential site for future RCTs (i.e., determine if there are enough caregivers in this clinic who might benefit from this specific supportive care strategy).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Males and female adults ≥18 years
  • Able to read and speak English
  • Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for >6 months
  • Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)

Exclusion criteria

  • Current participation in consistent (self-defined) psychotherapy
  • Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.

Treatment and study plan

Primary outcomes

  1. Quality of Life questionnaire (Qol)

    Time frame: through completion of study; approximately 1 month

Study contacts

Contact information is provided by the study sponsor or research team.

Juliet Kroll

CONTACT

[email protected]

(346) 723-5858

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • American Cancer Society, Inc.

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jun 15, 2023
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.